학술논문

Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients
Document Type
Journal
Source
NEUROMUSCULAR DISORDERS; OCT 2022, 32 pS62-pS62, 1p. Supplement: 1
Subject
Language
English
ISSN
18732364